Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 5/20 | 0.54 |
| ▸ | ANPEP | P15144 | 1/20 | 0.54 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.54 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.43 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | FABP4 | P15090 | 3/20 | 0.39 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9498619 | 0.85 | LAP3 (0.42) | LAP3ANPEPRNPEPDNPEPLTA4H | |
| SCHEMBL9500536 | 0.85 | LAP3 (0.42) | LAP3ANPEPRNPEPDNPEPLTA4H | |
| SCHEMBL9500894 | 0.85 | LAP3 (0.42) | LAP3ANPEPRNPEPDNPEPLTA4H | |
| SCHEMBL9500855 | 0.84 | LAP3 (0.41) | LAP3ANPEPRNPEPDNPEPLTA4H | |
| SCHEMBL9500612 | 0.82 | LAP3 (0.42) | LAP3ANPEPRNPEPDNPEPLTA4H | |
| SCHEMBL8012404 | 0.80 | LAP3 (0.58) | LAP3ANPEPRNPEPDNPEPLTA4H | |
| SCHEMBL9500847 | 0.79 | LAP3 (0.44) | LAP3ANPEPRNPEPDNPEPLTA4H | |
| SCHEMBL7439118 | 0.77 | MME (0.55) | ALDH1A1 | |
| SCHEMBL28799524 | 0.77 | LAP3 (0.64) | LAP3ANPEPRNPEPDNPEPLTA4H | |
| SCHEMBL28799521 | 0.77 | LAP3 (0.64) | LAP3ANPEPRNPEPDNPEPLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702005-A1 | CNDP2 MODULATORS AND METHODS FOR THEIR USE | Metabolon Inc. (US) | 2026-03-04 | — | — | EP | disclosed |
| US-20250120927-A1 | CNDP2 MODULATORS AND METHODS FOR THEIR USE | METABOLON INC. | 2025-04-17 | — | — | US | disclosed |
| WO-2024227056-A1 | CNDP2 MODULATORS AND METHODS FOR THEIR USE | METABOLON INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| EP-0333000-B1 | PEPTIDES WITH INHIBITORY ACTIVITY OF ENZYMATIC SYSTEMS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ZAMBON GROUP S.p.A. (IT) | 1993-05-19 | — | — | EP | disclosed |
| US-5145872-A | PEPTIDES WITH PHARMACEUTICAL ACTIVITY | ZAMBON GROUP, S.P.A. (IT) | 1992-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250120927-A1 | CNDP2 MODULATORS AND METHODS FOR THEIR USE | CNDP2, DPP7, DPEP1 | LAP3 131/4885ANPEP 54/4885RNPEP 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.